MCK News and Press, McKesson Corporation From 03/21/24

2024-03-21 10:22:39 ET More on Becton, Dickinson Becton, Dickinson And Company: Growth Starts To Normalize (Rating Upgrade) Becton, Dickinson and Company 2024 Q1 - Results - Earnings Call Presentation Becton, Dickinson and Company (BDX) Q1 2024 Earnings Call Transcri...

2024-03-10 03:56:46 ET Summary Third Point's portfolio is still top-heavy, with 10 stocks making up 70% of its AUM. The fund made a large trade by purchasing shares of Verizon and closing out its T-Mobile position. Third Point reduced its positions in Uber, Taiwan Semiconducto...

2024-03-05 22:43:45 ET Summary Dan Loeb's 13F portfolio value increased to $6.64B this quarter, with the top three holdings accounting for ~37% of the portfolio. Third Point returned 3.4% in 2023 compared to 26.3% for the S&P 500 Index. New stakes include Fleetcor Tech, Ve...

Shares of McKesson Corporation (NYSE: MCK) traded at a new 52-week high today and are currently trading at $531.16. So far today, approximately 143.05k shares have been exchanged, as compared to an average 30-day volume of 867.48k shares. McKesson Corporation provides healthcare supply chain ...

2024-02-28 06:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-02-26 01:44:56 ET Summary Bridgewater Associates' 13F portfolio value increased from ~$16.55B to ~$17.86B in Q4 2023. The top three individual stock positions are Procter & Gamble, Coca-Cola, and Costco. Stake increases include iShares Core S&P 500 ETF, Johnson &a...

2024-02-25 06:27:50 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...

2024-02-19 03:22:56 ET Summary McKesson reported 15% topline growth and 12.2% adjusted EPS growth in their recent earnings report. The company's GLP-1 medications have shown impressive growth, contributing 60% to year-over-year growth. McKesson's strong distribution network an...

2024-02-14 10:24:17 ET More on Cardinal Health, Cencora, etc. McKesson Corporation 2024 Q3 - Results - Earnings Call Presentation McKesson Corporation (MCK) Q3 2024 Earnings Call Transcript Cardinal Health, Inc. (CAH) Q2 2024 Earnings Call Transcript Argus up...

2024-02-08 15:00:10 ET Eric Coldwell from Robert W. Baird issued a price target of $567.00 for MCK on 2024-02-08 14:29:00. The adjusted price target was set to $567.00. At the time of the announcement, MCK was trading at $494.01. The overall price target consensus is at ...